New drug STP938 tested in patients with incurable cancers

NCT ID NCT06297525

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called STP938 in 70 adults with advanced solid tumors that cannot be cured by current treatments. The main goal is to check safety and find the right dose. The study also looks at how the drug moves through the body and includes a special group for patients with a specific type of ovarian cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Comprehensive Hematology Oncology, LLC

    RECRUITING

    St. Petersburg, Florida, 33709, United States

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, Paris, 94805, France

  • Mary Crowley Cancer Research Center

    RECRUITING

    Dallas, Texas, 75251, United States

  • Next Oncology

    RECRUITING

    San Antonio, Texas, 78292, United States

  • The Beatson Institute for Cancer Research

    RECRUITING

    Glasgow, Glasgow, G12 8QQ, United Kingdom

  • The Christie

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • University College London

    RECRUITING

    London, United Kingdom